A share price of Hims & Hers Health Inc [HIMS] is currently trading at $32.87, down -2.98%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The HIMS shares have gain 4.22% over the last week, with a monthly amount drifted -52.18%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on February 18, 2025, when Morgan Stanley downgraded its rating to a Equal-Weight and also boosted its price target to $60 from $42. Previously, Citigroup downgraded its rating to Sell on January 10, 2025, and elevated its price target to $25. On January 07, 2025, BTIG Research initiated with a Buy rating and assigned a price target of $35 on the stock. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $42 on December 17, 2024. BofA Securities downgraded its rating to a Underperform. Needham started tracking with a Buy rating for this stock on August 22, 2024, and assigned it a price target of $24. In a note dated August 09, 2024, Imperial Capital downgraded an In-line rating on this stock.
Hims & Hers Health Inc experienced fluctuations in its stock price throughout the past year between $11.20 and $72.98. Currently, Wall Street analysts expect the stock to reach $31.83 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $32.87 at the most recent close of the market. An investor can expect a potential drop of -3.16% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
Trailing Twelve Months sales for Hims & Hers Health Inc [NYSE:HIMS] were 1.48B which represents 95.09% growth. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.18, Equity is 0.31 and Total Capital is 0.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 32.07 points at the first support level, and at 31.27 for the second support level. However, for the 1st resistance point, the stock is sitting at 33.96, and for the 2nd resistance point, it is at 35.05.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Hims & Hers Health Inc [NYSE:HIMS] is 1.79. Further, the Quick Ratio stands at 1.50, while the Cash Ratio is 1.0. Considering the valuation of this stock, the price to sales ratio is 4.95, the price to book ratio is 15.23 and price to earnings (TTM) ratio is 61.46.
Transactions by insiders
Recent insider trading involved Carroll Patrick Harrison, Chief Medical Officer, that happened on Mar 18 ’25 when 23287.0 shares were sold. Chief Executive Officer, Dudum Andrew completed a deal on Mar 17 ’25 to sell 0.13 million shares. Meanwhile, Chief Executive Officer Dudum Andrew sold 78760.0 shares on Mar 18 ’25.
